Advanced search
Publication Cover
Acta Oncologica Volume 57, 2018 - Issue 7
Journal homepage
9,762
Views
37
CrossRef citations to date
0
Altmetric
Original Articles: Paediatic Cancer

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients

E. PalmeriniIstituto Ortopedico Rizzoli, Bologna, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3406-6705View further author information
ORCID Icon,
R. L. JonesRoyal Marsden Hospital and Institute of Cancer Research, London, UK; View further author information
,
E. SetolaIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
P. PicciIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
E. MarchesiIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
R. LukschIstituto Nazionale Tumori, Milan, Italy; View further author information
,
G. GrignaniCandiolo Cancer Institute – FPO, IRCCS, Torino, Italy; View further author information
,
M. CesariIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
A. LonghiIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
M. E. AbateIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
A. PaioliIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
Z. SzucsRoyal Marsden Hospital and Institute of Cancer Research, London, UK; View further author information
,
L. D’ambrosioCandiolo Cancer Institute – FPO, IRCCS, Torino, Italy; ORCID Iconhttp://orcid.org/0000-0003-3294-8819View further author information
ORCID Icon,
K. ScotlandiIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
,
F. FagioliOIRM, Torino, ItalyView further author information
,
S. AsafteiOIRM, Torino, ItalyView further author information
&
S. FerrariIstituto Ortopedico Rizzoli, Bologna, Italy; View further author information
 show all
Pages 958-964 | Received 23 Jan 2018, Accepted 23 Feb 2018, Published online: 13 Mar 2018

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Izzet Dogan, Ayca Iribas, Melin Aydan Ahmed & Mert Basaran. (2023) Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma. Journal of Chemotherapy 35:4, pages 343-347.
Read now
Deepam Pushpam, Vikas Garg, Sandip Ganguly & Bivas Biswas. (2020) Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects. OncoTargets and Therapy 13, pages 5093-5112.
Read now
David Van Mater & Lars Wagner. (2019) Management of recurrent Ewing sarcoma: challenges and approaches. OncoTargets and Therapy 12, pages 2279-2288.
Read now

Articles from other publishers (34)

Dan Su, Hujuan Yang, Ming Zhao, Hongying ZhouJin Wu, Zhongkuo Zhao, Jianguo Zhong, Qian XueYupeng HongJie Sun, Xiaoyi Li & Tongwei Zhao. (2023) Malignant gastrointestinal neuroectodermal tumor: a case report and literature review. Annals of Medicine & Surgery 85:12, pages 6196-6201.
Crossref
Sarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, Branka Radic-Sarikas, Eva Scheuringer, Lisa Bierbaumer, Vesnie Etienne, Fariba Némati, Susana Pascoal, Marcus Tötzl, Eleni M. Tomazou, Martin Metzelder, Eva M. Putz, Didier Decaudin, Olivier Delattre, Didier Surdez, Heinrich Kovar, Florian Halbritter & Martin Distel. (2023) High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma. Cancer Letters 554, pages 216028.
Crossref
Emily K. Slotkin & Paul A. Meyers. (2022) Irinotecan dose schedule for the treatment of Ewing sarcoma. Pediatric Blood & Cancer 70:1.
Crossref
Bi-Cheng Wang, Bo-Ya Xiao & Guo-He Lin. (2022) Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies. BMC Cancer 22:1.
Crossref
Gérard Milano, Federico Innocenti & Hironobu Minami. (2022) Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. Cancer Science 113:7, pages 2224-2231.
Crossref
Rachael Windsor, Anthony Hamilton, Anne McTiernan, Palma Dileo, Maria Michelagnoli, Beatrice Seddon, Sandra J. Strauss & Jeremy Whelan. (2022) Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma. European Journal of Cancer 170, pages 131-139.
Crossref
Hee Young Ju, Meerim Park, Jun Ah Lee, Hyeon Jin Park, Seog Yun Park, June Hyuk Kim, Hyun Guy Kang, Hee Chul Yang & Byung-Kiu Park. (2022) Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults. Cancer Research and Treatment 54:2, pages 563-571.
Crossref
Marit Ahrens. 2022. Therapie-Handbuch - Onkologie und Hämatologie. Therapie-Handbuch - Onkologie und Hämatologie 432 438 .
Jean-Yves Blay, Mehdi Brahmi, Perrine Marec-Berard, Nadege Corradini & Armelle Dufresne. 2022. Bone Cancer. Bone Cancer 755 766 .
Rebecca M. Hill, Sabine L. A. Plasschaert, Beate Timmermann, Christelle Dufour, Kristian Aquilina, Shivaram Avula, Laura Donovan, Maarten Lequin, Torsten Pietsch, Ulrich Thomale, Stephan Tippelt, Pieter Wesseling, Stefan Rutkowski, Steven C. Clifford, Stefan M. Pfister, Simon Bailey & Gudrun Fleischhack. (2021) Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment. Cancers 14:1, pages 126.
Crossref
Jose Duran Moreno, Georgios Papageorgiou, Ioanna Gazouli & Anastasios Kyriazoglou. (2021) Systemic Treatment of Ewing Sarcoma: Current Options and Future Perspectives. Forum of Clinical Oncology 12:3, pages 3-27.
Crossref
Holly J. Meany, Brigitte C. Widemann, Pamela S. Hinds, Rochelle Bagatell, Suzanne Shusterman, Emily Stern, Nalini Jayaprakash, Cody J. Peer, William D. Figg, O. Morgan Hall, Tristan M. Sissung, Aerang Kim, Elizabeth Fox, Wendy B. London, Carlos Rodriguez‐Galindo, Jane E. Minturn & Jeffrey S. Dome. (2021) Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors. Pediatric Blood & Cancer 68:11.
Crossref
O. M. Romantsova, D. V. Nisichenko, D. B. Khestanov, V. V. Khairullova, A. Z. Dzampaev & K. I. Kirgizov. (2021) Treatment of Ewingʼs sarcoma in children and adolescents: new vision. Russian Journal of Pediatric Hematology and Oncology 8:3, pages 30-42.
Crossref
Sergios Tsakatikas, George Papageorgiou, Rodanthi Fioretzaki & Christos Kosmas. (2021) An overview of current results with the vincristine-irinotecan-temozolomide combination with or without bevacizumab in pediatric, adolescence and adult solid tumors. Critical Reviews in Oncology/Hematology 166, pages 103457.
Crossref
Jie Xu, Lu Xie, Xin Sun, Kuisheng Liu, Xiaodong Tang, Taiqiang Yan, Rongli Yang, Wei Guo & Jin Gu. (2021) Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial. The Oncologist 26:7, pages e1256-e1262.
Crossref
Sebastian Dorin Asaftei, Nadia Puma, Anna Paioli, Marco Petraz, Carlo Morosi, Marta Podda, Angela Tamburini, Emanuela Palmerini, Luca Coccoli, Giovanni Grignani, Carla Manzitti, Rossella Bertulli, Francesco De Leonardis, Marco Rabusin, Anna Campello, Elisa Tirtei, Piero Picci, Arcangelo Prete, Alessandra Longhi, Franca Fagioli & Roberto Luksch. (2021) Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. Cancers 13:12, pages 3046.
Crossref
Kalasekhar VijayasekharanSubramaniam RamanathanGirish ChinnaswamyMaya PrasadAshish GuliaAmit JanuBharat RekhiMukta RamadwarNehal KhannaSiddhartha LaskarNilendu PuranadareJyoti BajpaiAjay PuriShripad BanavaliTushar Vora. (2021) High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen. Journal of Adolescent and Young Adult Oncology 10:2, pages 185-192.
Crossref
S. Salah, Y. H. To, O. Khozouz, T. Ismail, S. Yaser, A. Alnsour, O. Shahin, I. Sultan, R. Abuhijlih, H. Halalsheh, F. Abuhijla & J. Lewin. (2020) Irinotecan and temozolomide chemotherapy in paediatric and adult populations with relapsed Ewing Sarcoma. Clinical and Translational Oncology 23:4, pages 757-763.
Crossref
Georgios I. Papageorgiou, Sergios A. Tsakatikas, Rodanthi G. Fioretzaki & Christos Kosmas. (2020) Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab. Anti-Cancer Drugs 32:3, pages 330-336.
Crossref
Arthur Felix, Pablo Berlanga, Maud Toulmonde, Judith Landman‐Parker, Sarah Dumont, Gilles Vassal, Marie‐Cécile Le Deley & Nathalie Gaspar. (2021) Systematic review of phase‐I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research. Cancer Medicine 10:5, pages 1589-1604.
Crossref
Maria Anna Smolle, Joanna Szkandera, Dimosthenis Andreou, Emanuela Palmerini, Marko Bergovec & Andreas Leithner. (2020) Treatment options in unresectable soft tissue and bone sarcoma of the extremities and pelvis – a systematic literature review. EFORT Open Reviews 5:11, pages 799-814.
Crossref
Hui-Yun Gu, Chao Zhang, Jia Guo, Min Yang, Hou-Cheng Zhong, Wei Jin, Yang Liu, Li-Ping Gao & Ren-Xiong Wei. (2020) Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma. Aging 12:4, pages 3807-3827.
Crossref
Samson Ghilu, Qilin Li, Shaun D. Fontaine, Daniel V. Santi, Raushan T. Kurmasheva, Siyuan Zheng & Peter J. Houghton. (2020) Prospective use of the single-mouse experimental design for the evaluation of PLX038A. Cancer Chemotherapy and Pharmacology 85:2, pages 251-263.
Crossref
Stefano Ferrari & Emanuela Palmerini. 2020. Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions. Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions 237 239 .
Krysten A. Jones, Kaitlin Kentala, Michael W. Beck, Weiwei An, Alexander R. Lippert, Jared C. Lewis & Bryan C. Dickinson. (2019) Development of a Split Esterase for Protein–Protein Interaction-Dependent Small-Molecule Activation. ACS Central Science 5:11, pages 1768-1776.
Crossref
Choh Yeung, Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa, Ganesha Rai, Daniel J. Urban, Michelle S. Johnson, Gloria A. Benavides, Giuseppe L. Squadrito, Marielle E. Yohe, Haiyan Lei, Sandy Eldridge, John HamreIIIIII, Tyrone Dowdy, Victor Ruiz-Rodado, Adrian Lita, Arnulfo Mendoza, Jack F. Shern, Mioara Larion, Lee J. Helman, Gordon M. Stott, Murali C. Krishna, Matthew D. Hall, Victor Darley-Usmar, Leonard M. Neckers & Christine M. Heske. (2019) Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma. Cancer Research 79:19, pages 5060-5073.
Crossref
Christian Bailly. (2019) Irinotecan: 25 years of cancer treatment. Pharmacological Research 148, pages 104398.
Crossref
Darcy Welch, Elliot Kahen, Brooke Fridley, Andrew S. Brohl, Christopher L. Cubitt & Damon R. Reed. (2019) Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines. PLOS ONE 14:9, pages e0222228.
Crossref
Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, Alberto Righi, Giordano Nicoletti, Camilla Cristalli, Michela Pasello, Alessandro Parra, Marianna Carrabotta, Manuela Ferracin, Arianna Palladini, Marianna L. Ianzano, Veronica Giusti, Francesca Ruzzi, Mauro Magnani, Davide Maria Donati, Piero Picci, Pier-Luigi Lollini & Katia Scotlandi. (2019) Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations. Scientific Reports 9:1.
Crossref
Hiromichi Oshiro, Yasunori Tome, Tasuku Kiyuna, Kentaro Miyake, Kei Kawaguchi, Takashi Higuchi, Masuyo Miyake, Zhiying Zang, Sahar Razmjooei, Maryam Barangi, Sintawat Wangsiricharoen, Scott D. Nelson, Yunfeng Li, Michael Bouvet, Shree Ram Singh, Fuminori Kanaya & Robert M. Hoffman. (2019) Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model. Tissue and Cell 58, pages 17-23.
Crossref
Jie Xu, Lu Xie, Xin Sun, Sen Dong, Xiaodong Tang & Wei Guo. (2019) Management of recurrent or refractory Ewing sarcoma: A systematic review of phase�II clinical trials in the last 15�years. Oncology Letters.
Crossref
Kelly Bailey, Carrye Cost, Ian Davis, Julia Glade-Bender, Patrick Grohar, Peter Houghton, Michael Isakoff, Elizabeth Stewart, Nadia Laack, Jason Yustein, Damon Reed, Katherine Janeway, Richard Gorlick, Stephen Lessnick, Steven DuBois & Pooja Hingorani. (2019) Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force. F1000Research 8, pages 493.
Crossref
Tasuku Kiyuna, Yasunori Tome, Takashi Murakami, Kentaro Miyake, Kentaro Igarashi, Kei Kawaguchi, Hiromichi Oshiro, Takashi Higuchi, Masuyo Miyake, Norihiko Sugisawa, Zhiying Zhang, Sahar Razmjooei, Sintawat Wangsiricharoen, Bartosz Chmielowski, Scott D. Nelson, Tara A. Russell, Sarah M. Dry, Yunfeng Li, Mark A. Eckardt, Arun S. Singh, Sant Chawla, Fuminori Kanaya, Fritz C. Eilber, Shree Ram Singh, Ming Zhao & Robert M. Hoffman. (2018) A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model. Biochemical and Biophysical Research Communications 505:3, pages 733-739.
Crossref
. (2018) Irinotecan/temozolomide. Reactions Weekly 1718:1, pages 139-139.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.